Terms: = Breast cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Treatment
604 results:
1. Clinical assessment of momelotinib drug-drug interactions via CYP3A metabolism and transporters.
Ho YL; Gorycki P; Ferron-Brady G; Martin P; Vlasakakis G
Clin Transl Sci; 2024 Apr; 17(4):e13799. PubMed ID: 38634429
[TBL] [Abstract] [Full Text] [Related]
2. IFN‑γ induces apoptosis in gemcitabine‑resistant pancreatic cancer cells.
Kong X; Cheng D; Xu X; Zhang Y; Li X; Pan W
Mol Med Rep; 2024 May; 29(5):. PubMed ID: 38488034
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration.
Piscitelli J; Reddy MB; Wollenberg L; Del Frari L; Gong J; Wood L; Zhang Y; Matschke K; Williams JH
Clin Pharmacokinet; 2024 Apr; 63(4):483-496. PubMed ID: 38424308
[TBL] [Abstract] [Full Text] [Related]
4. Roles of breast cancer resistance protein and organic anion transporting polypeptide 2B1 in gastrointestinal toxicity induced by SN-38 under inflammatory conditions.
Gulnaz A; Lee KR; Kang MJ; Chang JE; Chae YJ
Toxicol Lett; 2024 Apr; 394():57-65. PubMed ID: 38423481
[TBL] [Abstract] [Full Text] [Related]
5. Drug-resistant profiles of extracellular vesicles predict therapeutic response in TNBC patients receiving neoadjuvant chemotherapy.
Kim MW; Lee H; Lee S; Moon S; Kim Y; Kim JY; Kim SI; Kim JY
BMC Cancer; 2024 Feb; 24(1):185. PubMed ID: 38326737
[TBL] [Abstract] [Full Text] [Related]
6. Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier.
Colón Ortiz R; Knerler S; Fridman LB; Mercado A; Price AS; Rosado-Franco JJ; Wilkins H; Flores BR; Orsburn BC; Williams DW
Fluids Barriers CNS; 2024 Jan; 21(1):5. PubMed ID: 38200564
[TBL] [Abstract] [Full Text] [Related]
7. Deciphering Potential Role of Hippo Signaling Pathway in breast cancer: A Comprehensive Review.
Bhavnagari H; Raval A; Shah F
Curr Pharm Des; 2023; 29(44):3505-3518. PubMed ID: 38141194
[TBL] [Abstract] [Full Text] [Related]
8. Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1.
Guo Y; Cui J; Liang X; Chen T; Lu C; Peng T
Int Immunopharmacol; 2024 Jan; 127():111407. PubMed ID: 38134594
[TBL] [Abstract] [Full Text] [Related]
9. Altering distribution profile of palbociclib by its prodrugs.
Järvinen J; Montaser AB; Adla SK; Leppänen J; Lehtonen M; Vellonen KS; Laitinen T; Jalkanen A; Elmquist WF; Timonen J; Huttunen KM; Rautio J
Eur J Pharm Sci; 2024 Jan; 192():106637. PubMed ID: 37967656
[TBL] [Abstract] [Full Text] [Related]
10. I-CBP112 declines overexpression of ATP-binding cassette transporters and sensitized drug-resistant MDA-MB-231 and A549 cell lines to chemotherapy drugs.
Strachowska M; Gronkowska K; Sobczak M; Grodzicka M; Michlewska S; Kołacz K; Sarkar T; Korszun J; Ionov M; Robaszkiewicz A
Biomed Pharmacother; 2023 Dec; 168():115798. PubMed ID: 37913733
[TBL] [Abstract] [Full Text] [Related]
11. Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer.
Kim SJ; Seo I; Kim MH; Park JW; Kim S; Park WJ
Lipids Health Dis; 2023 Oct; 22(1):183. PubMed ID: 37885013
[TBL] [Abstract] [Full Text] [Related]
12. Phloridzin Docosahexaenoate Inhibits Spheroid Formation by breast cancer Stem Cells and Exhibits Cytotoxic Effects against Paclitaxel-Resistant Triple Negative breast cancer Cells.
Fernando W; Clark RF; Rupasinghe HPV; Hoskin DW; Coombs MRP
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834020
[TBL] [Abstract] [Full Text] [Related]
13. Central Nervous System Distribution of Panobinostat in Preclinical Models to Guide Dosing for Pediatric Brain Tumors.
Zhang W; Oh JH; Zhang W; Rathi S; Larson JD; Wechsler-Reya RJ; Sirianni RW; Elmquist WF
J Pharmacol Exp Ther; 2023 Dec; 387(3):315-327. PubMed ID: 37827699
[TBL] [Abstract] [Full Text] [Related]
14. breast cancer resistance protein polymorphism abcg2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy.
Šušak Sporiš I; Božina N; Klarica Domjanović I; Sporiš D; Bašić S; Bašić I; Lovrić M; Ganoci L; Trkulja V
Fundam Clin Pharmacol; 2024 Apr; 38(2):351-368. PubMed ID: 37793994
[TBL] [Abstract] [Full Text] [Related]
15. Enhanced reversal of abcg2-mediated drug resistance by replacing a phenyl ring in baicalein with a meta-carborane.
Kuhnert L; Kuhnert R; Sárosi MB; Lakoma C; Scholz BK; Lönnecke P; Hey-Hawkins E; Honscha W
Mol Oncol; 2024 Feb; 18(2):280-290. PubMed ID: 37727134
[TBL] [Abstract] [Full Text] [Related]
16.
Kim H; Song TJ; Yee J; Kim DH; Park J; Gwak HS
Drug Des Devel Ther; 2023; 17():2513-2522. PubMed ID: 37641689
[TBL] [Abstract] [Full Text] [Related]
17. Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor-Darolutamide.
Podgoršek E; Mehra N; van Oort IM; Somford DM; Boerrigter E; van Erp NP
Clin Pharmacokinet; 2023 Aug; 62(8):1049-1061. PubMed ID: 37458966
[TBL] [Abstract] [Full Text] [Related]
18. Quinacrine inhibits HIF-1α/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and abcg2 in patient-derived breast cancer stem cells.
Das B; Dash SR; Patel H; Sinha S; Bhal S; Paul S; Das C; Pradhan R; Ahmed I; Goutam K; Kundu CN
Phytomedicine; 2023 Aug; 117():154914. PubMed ID: 37321076
[TBL] [Abstract] [Full Text] [Related]
19. Genetically Engineered Artificial Exosome-Constructed Hydrogel for Ovarian cancer Therapy.
Li Q; Song Q; Zhao Z; Lin Y; Cheng Y; Karin N; Luan Y
ACS Nano; 2023 Jun; 17(11):10376-10392. PubMed ID: 37194951
[TBL] [Abstract] [Full Text] [Related]
20. Transporter and metabolic enzyme-mediated intra-enteric circulation of SN-38, an active metabolite of irinotecan: A new concept.
Martha L; Nakata A; Furuya S; Liu W; Zhang X; Mizoi K; Ogihara T
Biochem Biophys Res Commun; 2023 Jul; 665():19-25. PubMed ID: 37148742
[TBL] [Abstract] [Full Text] [Related]
[Next]